Matthew J. Fraidakis
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Chenodeoxycholic acid rescues axonal degeneration in induced pluripotent stem cell-derived neurons from spastic paraplegia type 5 and cerebrotendinous xanthomatosis patients.
Journal: Orphanet journal of rare diseases
Published: May 18, 2022
The mitochondrial seryl-tRNA synthetase SARS2 modifies onset in spastic paraplegia type 4.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: May 06, 2022
No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patients.
Journal: Neurobiology of aging
Published: March 22, 2018
Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.
Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.
Journal: Brain : a journal of neurology
Published: May 02, 2017
TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
Journal: Human mutation
Published: October 10, 2016
Novel Compound Heterozygous Spatacsin Mutations in a Greek Kindred with Hereditary Spastic Paraplegia SPG11 and Dementia.
Journal: Neuro-degenerative diseases
Published: October 22, 2015
Cholestenoic acids regulate motor neuron survival via liver X receptors.
Journal: The Journal of clinical investigation
Published: March 17, 2014
Phenotypic diversity associated with the MT-TV gene m.1644G>A mutation, a matter of quantity.
Journal: Mitochondrion
Published: December 26, 2013
Psychiatric manifestations in cerebrotendinous xanthomatosis.
Journal: Translational psychiatry
Published: June 24, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026